🔗 Share this article

As America proceeds with unprecedented changes to its immunization schedules, an unexpected name appears somewhat surprisingly: Dr. Tracy Beth Høeg, a US-based sports medicine doctor and epidemiologist who initially gained attention by questioning coronavirus shots in the global health crisis and has zeroed in on potential deaths following Covid vaccination in her recent position at the Food and Drug Administration.

Proposed Overhauls to Childhood Immunization Program

Health officials had intended to reveal major revisions to the childhood vaccination calendar recently, aligning the US with the Danish immunization schedule, according to reports – a significant shift that would place the US out of step with a large portion of the world with insufficient data for public health gain. The announcement has been postponed until the new year.

In place of Vinay Prasad, Høeg is scheduled to present at the event. She was just designated acting director of the FDA’s CDER, the fifth individual to lead the division this calendar year.

A New Direction at the Agency

The acting appointment might represent a strengthened alliance between the drug and vaccine branches as Høeg and Dr. Prasad consolidate power at the regulatory agency – and it signals a renewed priority upon dismantling long-standing immunizations at the FDA.

The new acting director has frequently advocated for discontinuing specific pediatric immunization guidelines in the US to become more in line with Denmark, a society with comprehensive healthcare and a population approximately the population of the state of Wisconsin.

So far comments, she has continued to focus on immunizations – traditionally the purview of Prasad, chief of the FDA’s vaccine center – as opposed to drug regulation.

Questions Over Qualifications

Høeg has little discernible background in medication creation, regulation or management, which has been typical for former leaders of the biologics center. She has served at the FDA as a top consultant to the commissioner and the vaccine center since earlier this year.

“She appears not to have any of the qualifications” for running the CDER, stated Dr. Jonathan Howard. “She’s never run a scientific study. She is not versed in managing a major agency. She has no expertise in drug approvals.”

Previous directors of CBER would “grasp laws and regulations and the underlying principles of drug development”, said a former acting FDA commissioner. “Frankly, she lacks the type of experience that prior appointees who ran the center have had.”

This division has an immense workload at the FDA, Woodcock emphasized.

“The public just pays attention on the new drug program, but the generic program clears numerous generic medications. There is also a biologic copycat branch, over-the-counter program and more, and all of those must be managed,” Dr. Woodcock explained. “The thing you neglect, that is precisely what that I always told people is going to cause problems.”

There is also, a major management component to the role, which oversees in excess of 5,000 employees. “It’s a huge management job, if you perform it correctly,” Woodcock said.

Agency Reaction and Controversial Initiatives

When asked about concerns about Dr. Høeg's credentials and whether this appointment signifies increased cooperation among regulatory chiefs on immunizations, a spokesperson said that the “concerns are based on flawed assumptions”.

“This background is consistent with the functions of her position,” the spokesperson stated, pointing to the period Høeg spent advising the agency head on “pharmaceutical safety and approval science, including predictive safety algorithms and immunization monitoring”.

As acting director, Dr. Høeg inherits the commissioner’s new priority voucher program, a controversial expedited drug-approval program that reportedly troubled her predecessors. “How are these drugs being chosen for this expedited pathway? Who makes the decisions?” Howard said. “There is a lot of lack of transparency going on at the agency right now.”

Broadly speaking, he said, “the Food and Drug Administration looks to be trending towards less stringent regulations of all drugs, except for immunizations.”

Documented Track Record on Vaccines

With vaccines, Dr. Høeg has a clearer, if troubling, history, some experts observe. She published a study using unverified crowd-sourced reports to determine the rate of myocarditis following COVID-19 vaccination. She advised the Florida top health official Joseph Ladapo, who allegedly have changed statistics to suggest Covid vaccinations are pose a greater threat than they are.

Part of her “wish list” for the incoming administration included revising guidelines for recently developed shots and halting “non-essential” vaccines, she remarked after the election on a podcast. At the agency, Høeg has reportedly proposed preventing adolescent males from getting Covid vaccines.

“She’s an all-around true believer who commences with her beliefs and works backwards to accommodate the data in a highly misleading, dishonest manner,” Howard argued.

Consolidating Power and a “Revenge Tour”

Høeg aligned with other dissenters, {like|